Favorable effect of bortezomib in dense deposit disease associated with monoclonal gammopathy: a case report

BACKGROUND: Complement component 3 (C3) glomerulopathy, which includes dense deposit disease (DDD) and C3 glomerulonephritis, is caused by dysregulation of the alternative complement pathway. In most cases, C3 glomerulopathy manifests pathologically with membranoproliferative glomerulonephritis-like...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirashio, Shuma, Satoh, Ayaka, Arima, Takahiro, Mandai, Kouichi, Awaya, Tadasuke, Oshima, Kumi, Hara, Shigeo, Masaki, Takao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934801/
https://www.ncbi.nlm.nih.gov/pubmed/29724182
http://dx.doi.org/10.1186/s12882-018-0905-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934801/
https://www.ncbi.nlm.nih.gov/pubmed/29724182
http://dx.doi.org/10.1186/s12882-018-0905-6

Ejemplares similares